The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland-Reference-Cited by-同舟云学术

The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland

Published:2018-03 Issue: Volume:270 Page:132-138
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Pelczarska Aleksandra,Jakubczyk Michał,Jakubiak-Lasocka Joanna,Banach Maciej^ORCID,Myśliwiec Małgorzata,Gruchała Marcin,Niewada Maciej

Funder

Sanofi-Aventis, Warsaw, Poland

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Familial Hypercholesterolaemia: Identification and Management, Clinical Guideline [CG71], NICE [Internet]. https://www.nice.org.uk/guidance/cg71?unlid=666896701201512205758. (Accessed 19 December 2016).

2. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia;Goldberg;J Clin Lipidol,2011

3. Familial hypercholesterolaemia: a global call to arms;Vallejo-Vaz;Atherosclerosis,2015

4. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice;Catapano;Atherosclerosis,2016

5. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration;Vallejo-Vaz;Atherosclerosis Suppl.,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients;Atherosclerosis;2024-06

2. Newborn screening for lipid disorders;Current Opinion in Lipidology;2024-02-26

3. Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review;PharmacoEconomics;2024-01-24

4. Synthesized Economic Evidence on the Cost-effectiveness of Screening Familial Hypercholesterolemia: A meta-analytic review and Aggregate Distributional Cost-Effectiveness Analysis;2023-12-10

5. Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question;Current Opinion in Endocrinology, Diabetes & Obesity;2023-11-21